European Society of Cardiology Congress

Cardiology Today and Healio are pleased to offer highlights from the European Society of Cardiology Congress in Paris. Visit this page often for the latest news, video interviews and more. Also follow @CardiologyToday on Twitter for continuing updates.

Meeting News

RAPID-TnT: High-sensitivity troponin assay enables faster discharge in suspected ACS

September 5, 2019
PARIS — A 1-hour protocol including a high-sensitivity troponin T assay was associated with faster discharge of patients with suspected ACS…
Meeting News

OPTIMUS-5: Vorapaxar plus DAPT reduces thrombogenicity

September 5, 2019
PARIS — When added to dual antiplatelet therapy, vorapaxar reduced platelet-mediated thrombogenicity without impacting clot kinetics in…
Meeting NewsPerspective

POPular Genetics: Genotyping strategy for P2Y12 inhibitor selection after PCI yields less bleeding risk

September 4, 2019
PARIS — A strategy guided by CYP2C19 genotyping conferred reduced bleeding risk and similar thrombotic risk compared with standard treatment…
Meeting NewsPerspective

ENTRUST-AF PCI: Dual therapy with edoxaban noninferior to triple therapy in AF, PCI

September 4, 2019
PARIS — In patients with atrial fibrillation who underwent PCI, an antithrombotic strategy of edoxaban plus a P2Y12 inhibitor was noninferior…
Meeting News

ICDs reduce short- and long-term mortality in HFrEF

September 4, 2019
PARIS — Implantable cardioverter defibrillators were underutilized for primary prevention in patients with HF with reduced ejection fraction…
Meeting News

Statins, antiplatelets, RAAS inhibitors tied to mortality benefit after CABG: SWEDEHEART

September 4, 2019
PARIS — New data from the SWEDEHEART registry presented at the European Society of Cardiology Congress show that use of statins, antiplatelet…
Meeting News

Untreated aortic stenosis confers poor survival regardless if moderate or severe

September 4, 2019
PARIS — Patients with aortic stenosis have poor survival rates if their condition is left untreated, regardless of whether their stenosis is…
Meeting NewsVideo

VIDEO: Large, real-world analysis provides new insights on apixaban for nonvalvular AF

September 3, 2019
PARIS — In this video exclusive, P. Gabriel Steg, MD, FESC, provides investigator insight on NAXOS, the largest real-world analysis on the…
Meeting NewsPerspective

Twice-yearly inclisiran injection shows durable LDL improvement: ORION-11

September 3, 2019
PARIS — Inclisiran, an investigational cholesterol-lowering therapy in the small-interfering RNA class, achieved durable and potential LDL…
Meeting NewsPerspective

PURE: CVD accounts for more than 40% of deaths in low-, middle-income countries

September 3, 2019
PARIS — CVD was the leading cause of death in low-income countries, while cancer deaths were the top cause of death in some high-income and…